Rare disease clinical research network's urea cycle consortium delivers a successful clinical trial to improve alternate pathway therapy

Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis

(2010) Brendan M. McGuire et al.   HEPATOLOGY

Alternative pathway or diversion therapy for urea cycle disorders now and in the future

(2010) Stephen Cederbaum et al.   MOLECULAR GENETICS AND METABOLISM

Establishing a consortium for the study of rare diseases: The Urea Cycle Disorders Consortium

(2010) Jennifer Seminara et al.   MOLECULAR GENETICS AND METABOLISM

Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: Safety, pharmacokinetics and ammonia control

(2010) Brendan Lee et al.   MOLECULAR GENETICS AND METABOLISM

Clinical trials: Curing a critical deficiency in metabolic medicine

(2009) Jerry Vockley et al.   MOLECULAR GENETICS AND METABOLISM

Intellectual, Adaptive, and Behavioral Functioning in Children With Urea Cycle Disorders

(2009) Lauren Krivitzky et al.   PEDIATRIC RESEARCH